Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Onchocerciasis affecting the eye.
1 clinical trial registered. Interventions under study include drug therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
4 publications have been identified in PubMed for ocular onchocerciasis. Research spans Basic Science / Preclinical (50%) and Epidemiology / Natural History (50%).
Latrofa MS (2026). [PMID: 41586614](https://pubmed.ncbi.nlm.nih.gov/41586614/). *mSphere*. [Basic Science / Preclinical]
Dixon MA (2026). [PMID: 41766027](https://pubmed.ncbi.nlm.nih.gov/41766027/). *Communications medicine*. [Basic Science / Preclinical]
Kargbo-Labour I (2025). [PMID: 39825399](https://pubmed.ncbi.nlm.nih.gov/39825399/). *BMC research notes*. [Epidemiology / Natural History]
Sube KL (2024). [PMID: 39735383](https://pubmed.ncbi.nlm.nih.gov/39735383/). *Research and reports in tropical medicine*. [Epidemiology / Natural History]
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 6:18 AM UTC
AI-curated news mentioning ocular onchocerciasis
Updated Sep 13, 2026
A case report highlights the occurrence of intravitreal Onchocerca sp. infection alongside cerebral MRI lesions. This study contributes to the understanding of ocular manifestations associated with Onchocerca infections.